002653.SZ

Xizang Haisco Pharmaceutical Group Co Ltd · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$8.38B

PE Ratio

219.69

EV to Ebitda

—

Earnings Yield

0.00%

Revenue (TTM)

$645.4M

Net Income (TTM)

$38.2M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

12.00%

Profit Margin

6.00%

Return on Equity

—

Debt to Equity Ratio

0.25

Dividend Yield

1.00%

All fundamentals

Core6 fields›

Market Cap$8.38B

Revenue TTM$645.4M

Shares Outstanding1.12B

Float422376539

Insider Ownership76.00%

Institutional Ownership10.00%

Growth Estimates7 fields›

Revenue Growth (Quarterly YoY)12.00%

Rev Growth Est 1Y Forward0.2

EPS Growth (Quarterly YoY)-26.00%

EPS Growth Est Quarterly0

LT EPS Growth Estimates48.00%

FCF Growth (Quarterly YoY)206.00%

Dividend Growth (Quarterly YoY)-178.00%

Operations19 fields›

Revenue TTM$645.4M

Gross Margin TTM71.00%

Gross Margin (Quarterly)63.00%

Operating Margin TTM-16.00%

Operating Margin (Quarterly)-5.00%

Operating Expenses TTM$4.8M

Profit Margin TTM6.00%

Profit Margin (Quarterly)-3.00%

Net Income TTM$38.2M

EPS TTM0.23

EPS (Quarterly)-0.03

EBIT Margin TTM6.47%

EBITDA Margin TTM11.00%

EBITDA TTM$68.0M

CFO TTM$93.2M

Capex % of Revenue TTM8.00%

Capital Expenditures$48.8M

FCF % of Revenue (Quarterly)10.00%

FCF TTM$66.8M

Efficiency1 fields›

ROA2.00%

Valuation11 fields›

P/E (TTM)219.69

P/E Forward0

PEG0

P/FCF125.56

EV/Revenues (TTM)15.06

Price To Book13.29

Price to Tangible Book13.29

Earnings Yield0.00%

FCF Yield1.00%

Dividend Yield1.00%

Payout Ratio51.00%

Liquidity6 fields›

Current Ratio1.81

Total Assets$1.03B

Total Liabilities$1.68B

Shareholders Equity$631.0M

Debt to Equity0.25

Interest Expense$4.8M

Yields4 fields›

Dividend Yield1.00%

Payout Ratio51.00%

Earnings Yield0.00%

Buyback Yield0.00%